Third Coast Bancshares, Inc. (TCBX)

2seventy bio Stock Forecast

Stock Price Forecast

The 3 analysts that cover 2seventy bio stock have a consensus rating of "Hold" and an average price target of $39, which forecasts a 6.35% increase in the stock price over the next year. The lowest target is $36 and the highest is $42.

Price Target: $39 (+6.35%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$36	$39	$39	$42
Change	-1.83%	+6.35%	+6.35%	+14.54%

Analyst Ratings

The average analyst rating for 2seventy bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	2	1	1	1	1	1
Hold	2	3	3	3	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Woody Lay Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $38 → $42	Hold	Maintains	$38 → $42	+14.54%	Jul 28, 2025
Matt Olney Stephens & Co.	Stephens & Co.	Buy Maintains $44 → $39	Buy	Maintains	$44 → $39	+6.35%	Apr 25, 2025
Wood Lay Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $39 → $36	Hold	Maintains	$39 → $36	-1.83%	Apr 25, 2025
Michael Rose Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Apr 2, 2025
Wood Lay Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Buy → Hold Downgrades $40 → $42	Buy → Hold	Downgrades	$40 → $42	+14.54%	Jan 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

204.87M

Increased by 23.66%

from 165.68M

Revenue Next Year

218.11M

Increased by 6.46%

from 204.87M

EPS This Year

3.10

Increased by 11.33%

from 2.78

EPS Next Year

3.33

Increased by 7.58%

from 3.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	63.01M	85.51M	111.48M	141.41M	165.68M	204.87M	218.11M
Revenue Growth	87.86%	35.70%	30.37%	26.85%	17.16%	23.66%	6.46%
EPS	1.91	1.40	1.25	1.98	2.78	3.10	3.33
EPS Growth	218.33%	-26.70%	-10.71%	58.32%	40.59%	11.33%	7.58%
Forward PE	-	-	-	-	-	11.84	11.00
No. Analysts	-	-	-	-	-	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	212.3M	225.3M
Avg	204.9M	218.1M
Low	195.5M	208.5M

Revenue Growth

Revenue Growth	2025	2026
High	28.1%	10.0%
Avg	23.7%	6.5%
Low	18.0%	1.8%

EPS Forecast

EPS	2025	2026
High	3.32	3.55
Avg	3.10	3.33
Low	2.67	3.12

EPS Growth

EPS Growth	2025	2026
High	19.4%	14.6%
Avg	11.3%	7.6%
Low	-4.2%	0.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.